These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 36768520)

  • 1. The Cell-Specific Role of SHP2 in Regulating Bone Homeostasis and Regeneration Niches.
    Zhang J; Ye C; Zhu Y; Wang J; Liu J
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ptpn11 deletion in a novel progenitor causes metachondromatosis by inducing hedgehog signalling.
    Yang W; Wang J; Moore DC; Liang H; Dooner M; Wu Q; Terek R; Chen Q; Ehrlich MG; Quesenberry PJ; Neel BG
    Nature; 2013 Jul; 499(7459):491-5. PubMed ID: 23863940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHP2 regulates chondrocyte terminal differentiation, growth plate architecture and skeletal cell fates.
    Bowen ME; Ayturk UM; Kurek KC; Yang W; Warman ML
    PLoS Genet; 2014; 10(5):e1004364. PubMed ID: 24875294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted disruption of Shp2 in chondrocytes leads to metachondromatosis with multiple cartilaginous protrusions.
    Kim HK; Feng GS; Chen D; King PD; Kamiya N
    J Bone Miner Res; 2014 Mar; 29(3):761-9. PubMed ID: 23929766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SHP2 Regulates the Osteogenic Fate of Growth Plate Hypertrophic Chondrocytes.
    Wang L; Huang J; Moore DC; Zuo C; Wu Q; Xie L; von der Mark K; Yuan X; Chen D; Warman ML; Ehrlich MG; Yang W
    Sci Rep; 2017 Oct; 7(1):12699. PubMed ID: 28983104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SHP2 sails from physiology to pathology.
    Tajan M; de Rocca Serra A; Valet P; Edouard T; Yart A
    Eur J Med Genet; 2015 Oct; 58(10):509-25. PubMed ID: 26341048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
    Fragale A; Tartaglia M; Wu J; Gelb BD
    Hum Mutat; 2004 Mar; 23(3):267-77. PubMed ID: 14974085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase Separation of Disease-Associated SHP2 Mutants Underlies MAPK Hyperactivation.
    Zhu G; Xie J; Kong W; Xie J; Li Y; Du L; Zheng Q; Sun L; Guan M; Li H; Zhu T; He H; Liu Z; Xia X; Kan C; Tao Y; Shen HC; Li D; Wang S; Yu Y; Yu ZH; Zhang ZY; Liu C; Zhu J
    Cell; 2020 Oct; 183(2):490-502.e18. PubMed ID: 33002410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of Ptpn11 (Shp2) in cardiomyocytes causes dilated cardiomyopathy via effects on the extracellular signal-regulated kinase/mitogen-activated protein kinase and RhoA signaling pathways.
    Kontaridis MI; Yang W; Bence KK; Cullen D; Wang B; Bodyak N; Ke Q; Hinek A; Kang PM; Liao R; Neel BG
    Circulation; 2008 Mar; 117(11):1423-35. PubMed ID: 18316486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Biological Function of SHP2 in Human Disease].
    Li SM
    Mol Biol (Mosk); 2016; 50(1):27-33. PubMed ID: 27028808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine phosphatase
    Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
    Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noonan syndrome mutation Q79R in Shp2 increases proliferation of valve primordia mesenchymal cells via extracellular signal-regulated kinase 1/2 signaling.
    Krenz M; Yutzey KE; Robbins J
    Circ Res; 2005 Oct; 97(8):813-20. PubMed ID: 16166557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the protein tyrosine phosphatase SHP2 in ossification.
    Zhang Y; Lu W; Zhao Q; Chen J; Wang T; Ji J
    Dev Dyn; 2022 May; 251(5):748-758. PubMed ID: 34962674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases.
    Chen YN; LaMarche MJ; Chan HM; Fekkes P; Garcia-Fortanet J; Acker MG; Antonakos B; Chen CH; Chen Z; Cooke VG; Dobson JR; Deng Z; Fei F; Firestone B; Fodor M; Fridrich C; Gao H; Grunenfelder D; Hao HX; Jacob J; Ho S; Hsiao K; Kang ZB; Karki R; Kato M; Larrow J; La Bonte LR; Lenoir F; Liu G; Liu S; Majumdar D; Meyer MJ; Palermo M; Perez L; Pu M; Price E; Quinn C; Shakya S; Shultz MD; Slisz J; Venkatesan K; Wang P; Warmuth M; Williams S; Yang G; Yuan J; Zhang JH; Zhu P; Ramsey T; Keen NJ; Sellers WR; Stams T; Fortin PD
    Nature; 2016 Jul; 535(7610):148-52. PubMed ID: 27362227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noonan syndrome-causing SHP2 mutants impair ERK-dependent chondrocyte differentiation during endochondral bone growth.
    Tajan M; Pernin-Grandjean J; Beton N; Gennero I; Capilla F; Neel BG; Araki T; Valet P; Tauber M; Salles JP; Yart A; Edouard T
    Hum Mol Genet; 2018 Jul; 27(13):2276-2289. PubMed ID: 29659837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SH2 domain-containing phosphatase-2 protein-tyrosine phosphatase promotes Fc epsilon RI-induced activation of Fyn and Erk pathways leading to TNF alpha release from bone marrow-derived mast cells.
    McPherson VA; Sharma N; Everingham S; Smith J; Zhu HH; Feng GS; Craig AW
    J Immunol; 2009 Oct; 183(8):4940-7. PubMed ID: 19786542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LEOPARD-type SHP2 mutant Gln510Glu attenuates cardiomyocyte differentiation and promotes cardiac hypertrophy via dysregulation of Akt/GSK-3β/β-catenin signaling.
    Ishida H; Kogaki S; Narita J; Ichimori H; Nawa N; Okada Y; Takahashi K; Ozono K
    Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1531-9. PubMed ID: 21803945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered glucose homeostasis in mice with liver-specific deletion of Src homology phosphatase 2.
    Matsuo K; Delibegovic M; Matsuo I; Nagata N; Liu S; Bettaieb A; Xi Y; Araki K; Yang W; Kahn BB; Neel BG; Haj FG
    J Biol Chem; 2010 Dec; 285(51):39750-8. PubMed ID: 20841350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTPN11 (SHP2) Is Indispensable for Growth Factors and Cytokine Signal Transduction During Bovine Oocyte Maturation and Blastocyst Development.
    Idrees M; Xu L; Song SH; Joo MD; Lee KL; Muhammad T; El Sheikh M; Sidrat T; Kong IK
    Cells; 2019 Oct; 8(10):. PubMed ID: 31635340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of targeting SHP2 in human developmental disorders and cancers.
    Shen D; Chen W; Zhu J; Wu G; Shen R; Xi M; Sun H
    Eur J Med Chem; 2020 Mar; 190():112117. PubMed ID: 32061959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.